V Dousset1, C Gomez, K G Petry, C Delalande, J M Caille. 1. Laboratoire de Neurobiologie et Neuroimagerie Expérimentales, Université Victor Segalen Bordeaux 2, France. vincent.dousset@chu-aquitaine.fr
Abstract
RATIONALE AND OBJECTIVES: In experimental allergic encephalomyelitis (EAE), central nervous system (CNS) macrophage imaging is achievable by MRI using AMI-227 an ultra-small particle iron oxide contrast agent at a dose of 300 micromol/kg Fe. The objective was to test the feasibility at the human recommended dose of 45 micromol/kg Fe. METHODS: Two groups of EAE rats were tested with AMI-227 using 45 and 300 micromol/kg Fe respectively. Following i.v. injection of AMI-227, they were scanned after a delay of 4-6 and 20-24 h. RESULTS: With a high dose of AMI-227, all animals showed low signal intensity related to iron-loaded macrophages in the CNS. At low dose no abnormalities were found in the CNS. Furthermore, a delay of 4-6 h failed to demonstrate abnormalities even at high dose. CONCLUSIONS: Dose, scanning delay after administration and blood half-life are major parameters for T2* CNS macrophage imaging.
RATIONALE AND OBJECTIVES: In experimental allergic encephalomyelitis (EAE), central nervous system (CNS) macrophage imaging is achievable by MRI using AMI-227 an ultra-small particle iron oxide contrast agent at a dose of 300 micromol/kg Fe. The objective was to test the feasibility at the human recommended dose of 45 micromol/kg Fe. METHODS: Two groups of EAE rats were tested with AMI-227 using 45 and 300 micromol/kg Fe respectively. Following i.v. injection of AMI-227, they were scanned after a delay of 4-6 and 20-24 h. RESULTS: With a high dose of AMI-227, all animals showed low signal intensity related to iron-loaded macrophages in the CNS. At low dose no abnormalities were found in the CNS. Furthermore, a delay of 4-6 h failed to demonstrate abnormalities even at high dose. CONCLUSIONS: Dose, scanning delay after administration and blood half-life are major parameters for T2* CNS macrophage imaging.
Authors: Y Anzai; K E Blackwell; S L Hirschowitz; J W Rogers; Y Sato; W T Yuh; V M Runge; M R Morris; S J McLachlan; R B Lufkin Journal: Radiology Date: 1994-09 Impact factor: 11.105
Authors: V Dousset; C Delalande; L Ballarino; B Quesson; D Seilhan; M Coussemacq; E Thiaudiére; B Brochet; P Canioni; J M Caillé Journal: Magn Reson Med Date: 1999-02 Impact factor: 4.668
Authors: M E P Philippens; G Gambarota; J A Pikkemaat; W J M Peeters; A J van der Kogel; A Heerschap Journal: MAGMA Date: 2004-12-21 Impact factor: 2.310
Authors: V Dousset; B Brochet; M S A Deloire; L Lagoarde; B Barroso; J-M Caille; K G Petry Journal: AJNR Am J Neuroradiol Date: 2006-05 Impact factor: 3.825
Authors: Ming Yang; Gregory A Christoforidis; Tatiana Figueredo; Johannes T Heverhagen; Amir Abduljalil; Michael V Knopp Journal: Invest Radiol Date: 2005-10 Impact factor: 6.016
Authors: Klaus G Petry; Bruno Brochet; Vincent Dousset; Jean Rodolphe Vignes; Claudine Boiziau Journal: J Neural Transm (Vienna) Date: 2010-06-23 Impact factor: 3.575
Authors: Gregory A Christoforidis; Ming Yang; Marinos S Kontzialis; Douglas G Larson; Amir Abduljalil; Michelle Basso; Weilian Yang; Abhik Ray-Chaudhury; Johannes Heverhagen; Michael V Knopp; Rolf F Barth Journal: Invest Radiol Date: 2009-07 Impact factor: 6.016
Authors: Stephan Metz; Gabriel Bonaterra; Martina Rudelius; Marcus Settles; Ernst J Rummeny; Heike E Daldrup-Link Journal: Eur Radiol Date: 2004-07-13 Impact factor: 5.315